gonorrhea Diagnostics News

Sep 11, 2019

At-Home STI Testing Focus of Newly Standalone Firm Antelope Dx

Premium

Antelope's founder said that being spun off by MyCartis gives his company the focus it needs to launch tests for use in homes and doctors' clinics.

Sep 06, 2019

As M. Genitalium, Gonorrhea Molecular Testing Expands, Antibiotic Resistance Assays May Follow

Premium

New resistance tests for Mycoplasma genitalium and gonorrhea could help stave off superbugs, but guidelines and economic factors may hinder adoption.

Aug 27, 2019

After Years of Groundwork, Rapid STI MDx Space is Inaugurated With Binx FDA Clearance

Premium

The clearance of the Binx io CT/NG test marks a milestone for the Johns Hopkins University group that funds early-stage development of rapid STI testing.

Aug 21, 2019

MyCartis, Ghent University Spin Off Point-of-Care Testing Company Antelope Dx

MyCartis said that the new company, Antelope Dx, is developing a home test to diagnose Chlamydia trachomatis and Neisseria gonorrhea.

Aug 12, 2019

FDA Clears Binx Health Point-of-Care Testing Platform for Chlamydia, Gonorrhea

The firm said its platform provides sample-to-answer results for two of the most frequently tested sexually transmitted infections, enabling rapid testing and treatment.

Aug 05, 2019

SpeeDx Raises $15M in Equity Investment

The Australian molecular diagnostics firm will use the funds to accelerate commercial expansion in North America and global markets.

Jul 11, 2019

Enzo Biochem Gets NY Approval for Oral, Rectal CT/NG Test; Updates Lab Business Models

The latest NYS Department of Health approval expands the company's CT/NG testing to samples from multiple relevant body sites.

May 24, 2019

Startup Novel Microdevices Developing Rapid Point-of-Care MDx System for STIs

Premium

The company received support from a Johns Hopkins University center focused on point-of-care device development for sexually transmitted infections.

May 23, 2019

FDA Clears Cepheid, Hologic CT/NG Assays for Extragenital Testing

The Hologic Aptima Combo 2 and the Cepheid Xpert CT/NG assays have now been cleared for use in throat and rectum samples.

May 15, 2019

Binx Health Targeting Broader STI Screening With Rapid POC Platform

Premium

The firm is developing a multipanel test and an antibiotic resistance panel to augment its recently CE marked chlamydia and gonorrhea assay.

Menu

gonorrhea

At-Home STI Testing Focus of Newly Standalone Firm Antelope Dx

As M. Genitalium, Gonorrhea Molecular Testing Expands, Antibiotic Resistance Assays May Follow

After Years of Groundwork, Rapid STI MDx Space is Inaugurated With Binx FDA Clearance

MyCartis, Ghent University Spin Off Point-of-Care Testing Company Antelope Dx

FDA Clears Binx Health Point-of-Care Testing Platform for Chlamydia, Gonorrhea

SpeeDx Raises $15M in Equity Investment

Enzo Biochem Gets NY Approval for Oral, Rectal CT/NG Test; Updates Lab Business Models

Startup Novel Microdevices Developing Rapid Point-of-Care MDx System for STIs

FDA Clears Cepheid, Hologic CT/NG Assays for Extragenital Testing

Binx Health Targeting Broader STI Screening With Rapid POC Platform

Pages

Breaking News

Proteomics International Laboratories Transfers Diabetic Kidney Disease Test Tech to Atturos

PerkinElmer to Redeem Unsecured Notes

Todos Medical Inks Asian, North American Distribution Deal for Breast Cancer Tests

In Brief This Week: BioDiscovery, Diagnomics, Danaher, and More

Thermo Fisher to Redeem $1.1B Worth of Senior Notes

Quest Diagnostics, Hc1 Team Up to Launch Service for Optimizing Lab Test Utilization

What's Popular?

At-Home STI Testing Focus of Newly Standalone Firm Antelope Dx

Sponsorships